首页 >
法规速递
-
Page: Tacrolimus granules product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Document: Fingolimod capsules 0.25 and 0.5 mg product-specific bioequivalence guidance-2025/7/29
2025-07-30查看详情 > -
Page: Clinical trials in human medicines-2025/7/29
2025-07-30查看详情 > -
Page: Website outages and upgrades-2025/7/29
2025-07-30查看详情 > -
Document: Record of data processing activity in the context of selection and recruitment procedures-2025/7/29
2025-07-30查看详情 > -
Document: Summary of the Medicine Shortages SPOC Working Party meeting on 17 June 2025-2025/7/29
2025-07-30查看详情 > -
Page: Nitrosamine impurities-2025/7/29
2025-07-30查看详情 > -
Document: Report: European medicines regulatory network’s response to nitrosamine impurities in human medicines-2025/7/29
2025-07-30查看详情 > -
Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (20 June 2025 - 24 July 2025)-2025/7/28
2025-07-29查看详情 > -
Document: Start of procedure: Extension of marketing authorisation (20 June 2025 - 24 July 2025)-2025/7/28
2025-07-29查看详情 >